← Cancer Treatment and Research Communications
Papers in Cancer Treatment and Research Communications
Page 13 · newest first
- The incidence of colorectal cancer (CRC) in Georgia continues to increase: A population-based registry studyCancer Treatment and Research Communications · 2023
- Current and potential treatment of colorectal cancer metastasis to boneCancer Treatment and Research Communications · 2023
- Incidence and risk factors of unanticipated pathology in cases of hysterectomy for benign lesion a cross-section study in Al Shifa Medical ComplexCancer Treatment and Research Communications · 2023
- HPV testing for cervical cancer screening: Should reflex cytology be performed after a positive test for HPV 16 and 18?Cancer Treatment and Research Communications · 2023
- Downregulated miR-495-3p in colorectal cancer targets TGFβR1, TGFβR2, SMAD4 and BUB1 genes and induces cell cycle arrestCancer Treatment and Research Communications · 2023
- Pathological characteristics and tumour immune microenvironment of lung malignancies with RET rearrangementCancer Treatment and Research Communications · 2023
- Expression of Anaplastic Lymphoma Kinase (ALK) in glioma and possible clinical correlations. A retrospective institutional studyCancer Treatment and Research Communications · 2023
- Estrogen receptor and programmed death ligand-1 expression in type 1 endometrial cancer and its associated clinicopathological characteristicsCancer Treatment and Research Communications · 2023
- Survival outcomes and predicting intracranial metastasis in stage III non-small cell lung cancer treated with definitive chemoradiation: Real-world data from a tertiary cancer centerCancer Treatment and Research Communications · 2023
- Capecitabine efficacy after cycline-dependent-kinase 4/6 inhibitor plus endocrine therapy in metastatic hormone receptor-positive breast cancerCancer Treatment and Research Communications · 2023
- The copious capabilities of non-coding RNAs in cancer regulation, diagnosis and treatmentCancer Treatment and Research Communications · 2023
- Real-world treatment outcomes in HR+ HER2- metastatic breast cancer patients treated with CDK4/6 inhibitors: Results from a reference center in BrazilCancer Treatment and Research Communications · 2023
- Fatigue visual analogue scale score correlates with quality of life in cancer patients receiving epoetin alfa (Sandoz) for chemotherapy-induced anaemia: The CIROCO studyCancer Treatment and Research Communications · 2023
- Performing a radical trachelectomy with uterine transposition in a patient with stage IB2 cervical cancer: A case reportCancer Treatment and Research Communications · 2023
- Patient profiles, treatment patterns, and outcomes among persistent, recurrent, or metastatic cervical cancer patients under routine care in the United StatesCancer Treatment and Research Communications · 2023
- The prognostic impact of KRAS, TP53, STK11 and KEAP1 mutations and their influence on the NLR in NSCLC patients treated with immunotherapyCancer Treatment and Research Communications · 2023
- Time from immune checkpoint inhibitor to sotorasib use correlates with risk of hepatotoxicity in non-small cell lung cancer: A brief reportCancer Treatment and Research Communications · 2023
- Primary colorectal diffuse large B-cell lymphoma: A report of eighteen cases in a tertiary care centerCancer Treatment and Research Communications · 2023
- Synchronous endometrial and ovarian cancer and its recurrent risk factors: Case seriesCancer Treatment and Research Communications · 2023
- Immunotherapy for the elderly. Maybe the best option for lung cancer?Cancer Treatment and Research Communications · 2023
- Scope of PET imaging in the evaluation of cardiac tumorsCancer Treatment and Research Communications · 2023
- Clinical outcomes of stage-IV non–small-cell lung cancer in young patients and the impact of tumor markersCancer Treatment and Research Communications · 2023
- Molecular characterization of plasmacytoid urothelial carcinoma and the impact on treatment implicationsCancer Treatment and Research Communications · 2023
- A study of the efficacy and toxicity outcomes of extended durvalumab dosing in patients with stage III unresectable non-small cell lung cancer (NSCLC) during the COVID-19 pandemicCancer Treatment and Research Communications · 2022
- The association of body mass index with safety and effectiveness of first-line carboplatin-based chemotherapy in patients with metastatic non-small cell lung cancerCancer Treatment and Research Communications · 2022
- Impact of sex and age on adherence to guidelines in non-small cell lung cancer managementCancer Treatment and Research Communications · 2022
- A study of non small cell lung cancer (NSCLC) patients with brain metastasis: A single centre experienceCancer Treatment and Research Communications · 2022
- Intra-arterial hepatic bevacizumab and systemic chemotherapy in hepatic metastasis of colorectal cancer: A phase II multicentric trial in second-line treatmentCancer Treatment and Research Communications · 2022
- Evaluation of HE4 as a prognostic biomarker in uterine cervical cancer,Cancer Treatment and Research Communications · 2022
- A 10 year service evaluation of the survival of 439 patients with early oestrogen receptor positive breast cancer who underwent initial OncotypeDX ® testing to guide adjuvant chemotherapy decisionsCancer Treatment and Research Communications · 2022
- Efficacy of chemotherapy in patients with HR+/HER2–Invasive lobular breast cancerCancer Treatment and Research Communications · 2022
- Obstetric outcomes after cervical loop electrosurgical excision procedureCancer Treatment and Research Communications · 2022
- A comparison of cancer vaccine adjuvants in clinical trialsCancer Treatment and Research Communications · 2022
- Challenges and opportunities in the management of non-urothelial bladder cancersCancer Treatment and Research Communications · 2022
- Histopathological findings of oral epithelial dysplasias and their relation to malignant transformationCancer Treatment and Research Communications · 2022
- The impact of frailty on health outcomes in older adults with lung cancer: A systematic reviewSHILAP Revista de lepidopterología · 2022
- Similarities between wound re-epithelialization and Metastasis in ESCC and the crucial involvement of macrophages: A reviewSHILAP Revista de lepidopterología · 2022
- Prediction time of breast cancer tumor recurrence using Machine LearningSHILAP Revista de lepidopterología · 2022
- Hyperthermic intraperitoneal chemotherapy (HIPEC) after primary debulking surgery in advanced epithelial ovarian cancer: Is BRCA mutational status making the difference?SHILAP Revista de lepidopterología · 2022
- The miR-17-92 cluster: Yin and Yang in human cancersSHILAP Revista de lepidopterología · 2022
- A retrospective chart review of management strategies for lichenoid eruptions associated with immune-checkpoint inhibitor therapy from a single institutionSHILAP Revista de lepidopterología · 2022
- The significance of sarcomatoid and rhabdoid dedifferentiation in renal cell carcinomaCancer Treatment and Research Communications · 2022
- Periorbital edema associated with alpelisibCancer Treatment and Research Communications · 2022
- Multiple myeloma in Lebanon: Trend analysis, 10-year projections and comparisons to other countriesCancer Treatment and Research Communications · 2022
- Absolute eosinophil count predicts clinical outcomes and toxicity in non-small cell lung cancer patients treated with immunotherapyCancer Treatment and Research Communications · 2022
- Racial disparities in treatments and mortality among a large population-based cohort of older men and women with colorectal cancerCancer Treatment and Research Communications · 2022
- Eponyms in medical oncologyCancer Treatment and Research Communications · 2022
- Deep sequencing reveals the spectrum of BCR-ABL1 mutations upon front-line therapy resistance in chronic myeloid leukemia: An Eastern-Indian cohort studyCancer Treatment and Research Communications · 2022
- Primary tumor location and survival among metastatic colorectal cancer patients treated with systemic chemotherapy and biologic therapies: Retrospective analysisCancer Treatment and Research Communications · 2022
- Immunotherapy with GcMAF revisited - A critical overview of the research of Nobuto YamamotoCancer Treatment and Research Communications · 2022